GlassScriptPhysician profile
Maggie E Quinn
NPI 1962727255
$1,313.76
in general payments reported to CMS, 2019-2025
21 companies · $764 in 2025
The $764 reported for 2025 was more than what 75% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $191 · 2023: $202 · 2024: $49.78 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $232.83 | 2025 | Auvelity |
| Corium, LLC | $171.05 | 2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $142.58 | 2025 | Caplyta |
| Alexion Pharmaceuticals, INC. | $139.99 | 2021-2023 | Ultomiris |
| Mayne Pharma Commercial LLC | $97.55 | 2022-2025 | |
| Exeltis, USA INC. | $78.13 | 2021-2024 | Slynd |
| Abbvie INC. | $70.01 | 2025 | |
| Cmp Pharma, INC. | $65.58 | 2022-2023 | Norliqva |
| Avion Pharmaceuticals | $49.13 | 2022-2023 | Balcoltra |
| Azurity Pharmaceuticals, INC. | $35.59 | 2022 | |
| Kyowa Kirin, INC. | $31.54 | 2023-2024 | Crysvita |
| Vanda Pharmaceuticals INC. | $30.88 | 2025 | Hetlioz, Fanapt |
| Otsuka America Pharmaceutical, INC. | $30.24 | 2025 | Rexulti |
| Millicent US INC | $23.29 | 2025 | Femlyv |
| Ultragenyx Pharmaceutical INC. | $20.66 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $17.98 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $17.64 | 2025 | Zurzuvae |
| Mallinckrodt Hospital Products INC. | $16.25 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.81 | 2025 | Jornay Pm |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.80 | 2022 | |
| Merck Sharp & Dohme LLC | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maggie Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.